SILO
Silo Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
−4.90%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-60.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Dec 16, 2025 | Weisblum Eric · director, officer: Chief Executive Officer | Purchase | 2,500 | $0.42 |
| Nov 21, 2025 | Weisblum Eric · director, officer: Chief Executive Officer | Purchase | 1,000 | $0.36 |
| Nov 20, 2025 | Weisblum Eric · director, officer: Chief Executive Officer | Purchase | 4,500 | $0.41 |
| Nov 20, 2025 | Weisblum Eric · director, officer: Chief Executive Officer | Purchase | 7,500 | $0.40 |
| May 28, 2025 | Weisblum Eric · director, officer: Chief Executive Officer | Purchase | 10,000 | $0.43 |
| May 27, 2025 | Linsley Wayne · director | A-Award | 50,000 | $0.43 |
| May 27, 2025 | Munoz Kevin · director | A-Award | 50,000 | $0.43 |
| May 27, 2025 | Ryweck Daniel E. · officer: Chief Financial Officer | A-Award | 50,000 | $0.43 |
| May 27, 2025 | Weisblum Eric · director, officer: Chief Executive Officer | A-Award | 200,000 | $0.43 |
| May 27, 2025 | Pavell Jeff · director | A-Award | 50,000 | $0.43 |
| Dec 16, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 2,500 | $0.84 |
| Nov 22, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 2,500 | $0.90 |
| Jun 13, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 4,438 | $1.11 |
| Jun 13, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 562 | $1.08 |
| Apr 8, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 400 | $2.03 |
| Apr 8, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 600 | $1.96 |
| Apr 1, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 1,100 | $1.91 |
| Apr 1, 2024 | Weisblum Eric · director, officer: CEO and President | Purchase | 3,408 | $1.94 |
| Dec 21, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 200 | $1.61 |
| Dec 21, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 500 | $1.63 |
| Dec 18, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 900 | $1.52 |
| Dec 18, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 200 | $1.50 |
| Dec 7, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 324 | $1.36 |
| Dec 7, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 76 | $1.34 |
| Dec 7, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 600 | $1.39 |
| Nov 30, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 1,000 | $1.53 |
| Nov 27, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 250 | $1.78 |
| Nov 27, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 400 | $1.68 |
| Nov 22, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 300 | $1.56 |
| Nov 22, 2023 | Weisblum Eric · director, officer: CEO and President | Purchase | 4,050 | $1.60 |
Institutional positioning
13F filings over the trailing two quarters
New 6Increased 4Reduced 3Sold out 15
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | Increased | 663,965 | Apr 28, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 180,031 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 62,795 | May 15, 2026 |
| JANE STREET GROUP, LLC | Increased | 44,763 | May 12, 2026 |
| CITADEL ADVISORS LLC | New Position | 21,448 | May 15, 2026 |
| XTX TOPCO LTD | Reduced | 17,083 | May 15, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 14,503 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 13,100 | May 8, 2026 |
| LPL FINANCIAL LLC | New Position | 12,534 | May 6, 2026 |
| STATE STREET CORP | Unchanged | 12,500 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 11,221 | May 15, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 1,677 | May 15, 2026 |
| IFP ADVISORS, INC | New Position | 175 | Apr 13, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 10 | Jul 8, 2026 |
| CITIGROUP INC | Reduced | 1 | May 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Dec 16, 2025